Eric S Fain Net Worth - Insider Trades and Bio as of May 19, 2026

Eric S Fain's Net Worth

$77.1 Million

Estimate Recalculated May 18, 2026 08:25PM EST

Who is Eric S Fain

Eric S Fain has an estimated net worth of $77.1 Million. This is based on reported shares across multiple companies, which include ST JUDE MEDICAL INC, ABBOTT LABORATORIES, and Orchestra BioMed Holdings, Inc..

SEC CIK

Eric S Fain's CIK is 0001402222

Past Insider Trading and Trends

2013 was Eric S Fain's most active year for acquiring shares with 11 total transactions. Eric S Fain's most active month to acquire stocks was the month of November. 2008 was Eric S Fain's most active year for disposing of shares, totalling 104 transactions. Eric S Fain's most active month to dispose stocks was the month of December. 2016 saw Eric S Fain paying a total of $4,587,000.00 for 161,665 shares, this is the most they've acquired in one year. In 2016 Eric S Fain cashed out on 271,806 shares for a total of $8,782,120.72, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ST JUDE MEDICAL, LLC

Group President

Updated Jan 06, 2017


Form 4	-100.00%	-1.05M	—	—	Jan 06, 2017	—	Disposition	—	Jan 04
Form 4	-1.82%	-5.02K	$79.20	-$397.90K	Dec 20, 2016	276.89K	Options	—	Dec 17
Form 4	-45.65%	-105.12K	$55.17	-$3.80M	Dec 16, 2016	125.18K	Options	—	Dec 12 - Dec 14
Form 4	-1.79%	-4.67K	$61.06	-$285.46K	Dec 21, 2015	256.71K	Options	—	Dec 17
Form 4	—	115.50K	—	—	Dec 09, 2015	115.50K	Grant	—	Dec 07
Form 4	-38.34%	-47.00K	$57.20	-$1.56M	Apr 28, 2015	75.59K	Sale	Scheduled	Apr 24
Form 4	-2.67%	-2.50K	$65.61	-$163.83K	Dec 19, 2014	90.99K	Options	—	Dec 17
Form 4	—	91.72K	—	—	Dec 10, 2014	91.72K	Grant	—	Dec 08
Form 4	-2.45%	-2.09K	$59.42	-$124.07K	Dec 17, 2013	83.27K	Options	—	Dec 17
Form 4	136.82%	95.17K	—	—	Dec 12, 2013	164.73K	Grant	—	Dec 02 - Dec 10
Form 4	—	145.50K	$47.92	$1.70M	Oct 22, 2013	116.56K	Sell-Options	Scheduled	Oct 18
Form 4	-3.83%	-2.74K	$42.31	-$116.06K	Feb 08, 2013	68.95K	Sale	—	Feb 07
Form 4	—	166.00K	—	—	Dec 12, 2012	237.69K	Grant	—	Dec 10
Form 4	—	200.00K	—	—	Dec 14, 2011	200.00K	Grant	—	Dec 12
Form 4	-0.32%	-233.00	$48.58	-$11.32K	Jul 01, 2011	71.56K	Tax	—	Jul 01
Form 4	-21.79%	-20.00K	$41.76	-$432.40K	May 10, 2011	71.80K	Sale	—	May 06
Form 4	-28.62%	-36.80K	$42.26	-$832.05K	May 02, 2011	91.80K	Sale	—	Apr 28
Form 4	—	144.50K	—	—	Dec 16, 2010	144.50K	Grant	—	Dec 14
Form 4	-46.67%	-63.00K	$28.45	-$1.40M	Dec 03, 2010	71.98K	Sale	Scheduled	Dec 01
Form 4	-0.26%	-184.00	—	—	Jul 02, 2010	71.18K	Tax	—	Jul 01
Form 4	195.05%	139.72K	—	—	Dec 16, 2009	211.36K	Grant	—	Dec 14
Form 4	-48.40%	-67.50K	$26.63	-$1.13M	Oct 29, 2009	71.97K	Sale	Scheduled	Oct 27
Form 4	—	—	$6.77	$81.24K	Sep 17, 2009	71.97K	Options	—	Sep 15
Form 4	-29.26%	-52.50K	$24.74	-$1.37M	Jul 28, 2009	126.93K	Sale	Scheduled	Jul 24
Form 4	-0.38%	-229.00	—	—	Jul 02, 2009	59.43K	Tax	—	Jul 01
Form 4	-62.63%	-100.00K	$26.78	-$2.01M	Feb 11, 2009	59.66K	Sale	—	Feb 09
Form 4	—	150.00K	—	—	Dec 17, 2008	150.00K	Grant	—	Dec 15
Form 4	-23.89%	-50.00K	$31.84	-$1.51M	Jul 25, 2008	159.32K	Sale	Scheduled	Jul 23
Form 4	-0.39%	-230.00	—	—	Jul 03, 2008	59.32K	Tax	—	Jul 01
Form 4	-5.68%	-3.60K	$42.01	-$151.23K	Jan 25, 2008	59.83K	Sale	Scheduled	Jan 23
Form 4	-13.62%	-10.00K	$41.59	-$415.93K	Jan 25, 2008	63.43K	Sale	Scheduled	Jan 23
Form 4	-14.25%	-12.20K	$40.80	-$497.75K	Jan 25, 2008	73.43K	Sale	Scheduled	Jan 23
Form 4	-9.31%	-24.20K	$28.46	-$134.30K	Jan 25, 2008	235.63K	Sale	Scheduled	Jan 23
Form 4	—	94.00K	—	—	Dec 12, 2007	94.00K	Grant	—	Dec 10
Form 4	-40.23%	-40.00K	$28.99	-$1.27M	Jul 26, 2007	59.42K	Sale	—	Jul 25
Form 4	48.76%	28.00K	$41.49	$82.98K	Jul 03, 2007	85.42K	Grant	—	Jul 01
Form 3	—	—	—	—	Jul 03, 2007	57.42K	—	—	—

Showing 37 results

ABBOTT LABORATORIES

Senior Vice President

Updated Sep 29, 2017

View Quote Details


Form 4/A	-4.46%	-23.09K	—	—	Sep 29, 2017	493.96K	Disposition	—	Jul 21
Form 4	-5.14%	-28.01K	$50.85	-$1.42M	Jul 25, 2017	517.05K	Tax	—	Jul 21
Form 4/A	5,458.19%	114.24K	—	—	Jul 25, 2017	116.33K	Grant	—	Jan 04
Form 3/A	—	—	—	—	Jul 25, 2017	2.09K	—	—	—
Form 4	35.08%	182.74K	—	—	Feb 22, 2017	703.71K	Grant	—	Feb 17
Form 4	54,199.07%	812.99K	—	—	Jan 06, 2017	814.49K	Grant	—	Jan 04
Form 3	—	—	—	—	Jan 06, 2017	1.50K	—	—	—

Showing 7 results

Orchestra BioMed Holdings, Inc.

Investor

Updated Aug 25, 2025

View Quote Details


Form 4	8.73%	5.76K	$2.61	$15.03K	Aug 25, 2025	71.71K	Purchase	—	Aug 25
Form 4	29.44%	15.00K	—	—	Aug 08, 2025	65.95K	Grant	—	Aug 07
Form 4	-5.00%	-2.68K	$3.05	-$8.18K	Jun 27, 2025	50.95K	Sale	—	Jun 26
Form 4	119.43%	49.22K	—	—	Jun 26, 2025	90.43K	Grant	—	Jun 24
Form 4	-6.11%	-5.60K	$5.52	-$30.67K	Sep 10, 2024	86.02K	Sale	—	Sep 06 - Sep 10
Form 4	54.17%	22.44K	—	—	Jun 21, 2024	63.88K	Grant	—	Jun 20
Form 4	97.98%	29.17K	—	—	Jul 24, 2023	58.93K	Grant	—	Jul 20
Form 4/A	—	23.25K	—	—	May 19, 2023	23.25K	Grant	—	Jan 26
Form 4	—	—	$1.08	$3.14K	May 12, 2023	29.77K	Options	—	May 10
Form 4	—	—	—	—	May 05, 2023	31.66K	Options	—	Apr 12
Form 4/A	—	9.59K	—	—	May 05, 2023	9.59K	Grant	—	Jan 26
Form 4	—	73.80K	—	—	Jan 30, 2023	73.80K	Grant	—	Jan 26
Form 3	—	—	—	—	Jan 30, 2023	—	—	—	—

Showing 13 results